Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02978378 · ClinicalTrials.gov registry record
Renal Biomarkers to Predict Recovery Following Venoarterial Extracorporeal Membrane Oxygenation
A clinical trial, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02978378: Clinical Trial study, sponsored by Milton S. Hershey Medical Center.
NCT02978378 is a clinical trial that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02978378 was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The investigators objective is to assess the utility of renal biomarkers in predicting renal recovery following institution of Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO). Tissue biomarkers of renal injury may provide a real-time indication of renal function and the likelihood of renal recovery in patients having cardiogenic shock and requiring VA-ECMO. In these patients, traditional markers of kidney function (urine output and serum Creatinine level) do not accurately represent renal function.
Interventions
- OTHER biomarker levels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2018-03-23 |
Why NCT02978378 stopped before completion
NCT02978378 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which biomarker levels is the first listed.
NCT02978378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02978378 about?
NCT02978378 is a clinical study titled "Renal Biomarkers to Predict Recovery Following Venoarterial Extracorporeal Membrane Oxygenation". The investigators objective is to assess the utility of renal biomarkers in predicting renal recovery following institution of Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO). Tissue biomarkers of renal injury may provide a real-time indication of renal function and the likelihood of rena...
What is the current status of trial NCT02978378?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2017-05-01. Estimated completion is 2018-03-23.
What interventions are being tested in trial NCT02978378?
The interventions under investigation include: biomarker levels (OTHER).
Who is sponsoring clinical trial NCT02978378?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI